tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Revenue

Compare
350 Followers

Day One Biopharmaceuticals Revenue

Day One Biopharmaceuticals had a revenue of 33.91M in the quarter ending Jun 30, 2025, with 10.23%. This bring the company's revenue in the last twelve months to 187.64M, Decreased 15.88%. In the fiscal year ending Dec 31, 2024, Day One Biopharmaceuticals had annual revenue of 131.16M with Infinity% growth.
Revenue (ttm)
187.64M
Revenue Growth
2190.50%
P/S Ratio
5.45
Revenue/Employee
$724,646
Employees
181
Market Cap
$714.97M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
131.16M+∞%
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis